H.R. 6190: Asthma Inhalers Relief Act of 2012

112th Congress, 2011–2012

To direct the Administrator of the Environmental Protection Agency to allow for the distribution, sale, and consumption in the United States of remaining inventories of over-the-counter CFC epinephrine inhalers.

Sponsor:
Rep. Michael Burgess [R-TX26]
Status:
Failed Under Suspension

The bill’s title and summary above were written by the bill’s sponsor. H.R. stands for House of Representatives bill.

Track this bill
(About Ads | Advertise Here)

Bill Overview

Status:
Introduced Jul 25, 2012
Referred to Committee Jul 25, 2012
Reported by Committee Sep 14, 2012
Failed Under Suspension Dec 12, 2012
Passed House (not yet occurred)
Passed Senate (not yet occurred)
Signed by the President (not yet occurred)
This bill is provisionally dead due to a failed vote on December 12, 2012 under a fast-track procedure called "suspension." It may or may not get another vote.
Votes:

House: On Motion to Suspend the Rules and Pass
Dec 12, 2012 5:16 p.m.
Failed 229/182

Prognosis:

27% chance of being enacted.

Only 29% of House bills that made it past committee in 2009–2010 were enacted. show factors

Text:
Cosponsors:
show cosponsors (5)
Committees:

House Committee on Energy and Commerce

The committee chair determines whether a bill will move past the committee stage.

Primary Source

THOMAS (The Library of Congress)
THOMAS is updated generally one day after events occur and events since the last update may not be reflected here.

Citation

This page can be cited in one of these formats (click for details): APA, MLA, Wikipedia Template.

Related Bills:

Search for similar bills.

Subject Areas:

Use these subject areas to explore related legislation:

Official Summary

This summary was written by the Congressional Research Service, a nonpartisan arm of the Library of Congress. GovTrack did not write and has no control over these summaries.

9/14/2012--Reported to House without amendment.
(This measure has not been amended since it was introduced.
The summary of that version is repeated here.) Asthma Inhalers Relief Act of 2012 - Directs the Administrator of the Environmental Protection Agency (EPA) to:
(1) permit the distribution, sale, and consumption in the United States of remaining inventories of CFC epinephrine inhalers manufactured pursuant to the exception for medical devices under the Clean Air Act;
(2) not take any enforcement action or otherwise seek to restrict the distribution, sale, or consumption of such inhalers on the basis of any federal law implementing the Montreal Protocol on Substances that Deplete the Ozone Layer; and
(3) issue, in response to a request of any distributor or seller of such inhalers, a No Action Assurance Letter stating that the EPA will not initiate an enforcement action relating to the distribution or sale of any such inhaler occurring prior to August 1, 2013.
Defines "CFC epinephrine inhaler" to mean any epinephrine inhaler containing chlorofluorocarbons that was manufactured and classified as over-the-counter before January 1, 2012.
Terminates this Act on August 1, 2013.